Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents.

Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Harrell S, Rubinstein SM, Hall R, Wyatt H, Piazza G
Br J Haematol. 2020 190 (4): 555-561

PMID: 32314352 · DOI:10.1111/bjh.16653

MeSH Terms (25)

Aged Comorbidity Consolidation Chemotherapy Factor Xa Inhibitors Female Hemorrhage Humans Immunologic Factors Lenalidomide Maintenance Chemotherapy Male Middle Aged Multiple Myeloma Myocardial Infarction Pilot Projects Proof of Concept Study Prospective Studies Pulmonary Embolism Pyrazoles Pyridones Stroke Thalidomide Thrombophilia Venous Thromboembolism Venous Thrombosis

Connections (1)

This publication is referenced by other Labnodes entities: